TY - JOUR
T1 - Interactions of Phenylalanine Derivatives with Human Tyrosinase
T2 - Lessons from Experimental and Theoretical tudies
AU - Faure, Clarisse
AU - Min Ng, Yi
AU - Belle, Catherine
AU - Soler-Lopez, Montserrat
AU - Khettabi, Lyna
AU - Saïdi, Mélissa
AU - Berthet, Nathalie
AU - Maresca, Marc
AU - Philouze, Christian
AU - Rachidi, Walid
AU - Réglier, Marius
AU - du Moulinet d'Hardemare, Amaury
AU - Jamet, Hélène
N1 - Publisher Copyright:
© 2024 The Authors. ChemBioChem published by Wiley-VCH GmbH.
PY - 2024/6/17
Y1 - 2024/6/17
N2 - The pigmentation of the skin, modulated by different actors in melanogenesis, is mainly due to the melanins (protective pigments). In humans, these pigments’ precursors are synthetized by an enzyme known as tyrosinase (TyH). The regulation of the enzyme activity by specific modulators (inhibitors or activators) can offer a means to fight hypo- and hyper-pigmentations responsible for medical, psychological and societal handicaps. Herein, we report the investigation of phenylalanine derivatives as TyH modulators. Interacting with the binuclear copper active site of the enzyme, phenylalanine derivatives combine effects induced by combination with known resorcinol inhibitors and natural substrate/intermediate (amino acid part). Computational studies including docking, molecular dynamics and free energy calculations combined with biological activity assays on isolated TyH and in human melanoma MNT-1 cells, and X-ray crystallography analyses with the TyH analogue Tyrp1, provide conclusive evidence of the interactions of phenylalanine derivatives with human tyrosinase. In particular, our findings indicate that an analogue of L–DOPA, namely (S)-3-amino-tyrosine, stands out as an amino phenol derivative with inhibitory properties against TyH.
AB - The pigmentation of the skin, modulated by different actors in melanogenesis, is mainly due to the melanins (protective pigments). In humans, these pigments’ precursors are synthetized by an enzyme known as tyrosinase (TyH). The regulation of the enzyme activity by specific modulators (inhibitors or activators) can offer a means to fight hypo- and hyper-pigmentations responsible for medical, psychological and societal handicaps. Herein, we report the investigation of phenylalanine derivatives as TyH modulators. Interacting with the binuclear copper active site of the enzyme, phenylalanine derivatives combine effects induced by combination with known resorcinol inhibitors and natural substrate/intermediate (amino acid part). Computational studies including docking, molecular dynamics and free energy calculations combined with biological activity assays on isolated TyH and in human melanoma MNT-1 cells, and X-ray crystallography analyses with the TyH analogue Tyrp1, provide conclusive evidence of the interactions of phenylalanine derivatives with human tyrosinase. In particular, our findings indicate that an analogue of L–DOPA, namely (S)-3-amino-tyrosine, stands out as an amino phenol derivative with inhibitory properties against TyH.
KW - human tyrosinase
KW - molecular modelling
KW - organic synthesis
KW - tyrosinase inhibitor
KW - X-ray crystallography
UR - http://www.scopus.com/inward/record.url?scp=85195362452&partnerID=8YFLogxK
U2 - 10.1002/cbic.202400235
DO - 10.1002/cbic.202400235
M3 - Article
C2 - 38642076
AN - SCOPUS:85195362452
SN - 1439-4227
VL - 25
JO - ChemBioChem
JF - ChemBioChem
IS - 12
M1 - e202400235
ER -